Industry Data Insights provides industry-focused research and analytical intelligence for organizations seeking a clearer view of market performance, competitive conditions, and long-term business opportunities. Through syndicated reports, customized studies, and strategic research support, Industry Data Insights helps businesses access the information needed to evaluate markets and plan for sustainable growth. Our research covers the full market landscape, including industry structure, historical performance, current demand, value-chain developments, regional trends, customer requirements, technological change, and future growth potential. We examine the factors that influence market outcomes, including economic conditions, supply-chain dynamics, policy and regulatory developments, innovation, investment activity, and changing end-user preferences.
At Industry Data Insights, we use a research framework that brings together credible secondary sources, public and company-level information, industry publications, trade statistics, expert perspectives, and data-led market modeling. Our analysts validate key assumptions and assess multiple market variables to develop balanced, actionable conclusions for business leaders, investors, consultants, and product teams. Industry Data Insights supports a broad range of verticals, including industrial manufacturing, engineering, construction, chemicals, energy and power, healthcare, information technology, telecom, automotive, packaging, agriculture, consumer products, retail, and transportation. Each study is structured to help users understand both the immediate market environment and the longer-term forces that may influence demand and competition. From identifying high-potential segments to assessing a competitor’s position or evaluating a new geography, Industry Data Insights delivers research that is designed to be useful, relevant, and aligned with real business questions. Our goal is to turn industry data into strategic direction.
Sep 15 2026
274
.jpg){kind=small}
Research Analyst
Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.
See the similar reports
| Metric | Value |
|---|---|
| Base Year Valuation (2025) | $4.8 Billion |
| Forecast Valuation (2033) | $9.2 Billion |
| CAGR (2025-2033) | 8.5% |
| Forecast Period | 2025–2033 |
| Largest Regional Market | North America (35% share) |
| Dominant Segment | Collagen (Ingredient) |
The anti-aging supplements market is poised for robust expansion, driven by an aging global population and increasing consumer focus on preventive health. Valued at $4.8 billion in 2025, the market is projected to nearly double to $9.2 billion by 2033, registering a CAGR of 8.5%. This growth outpaces the broader Global Nutraceuticals Market, which is expanding at approximately 7% annually. The Anti-Aging Nutraceuticals Market is benefiting from rising demand for collagen, NMN, and resveratrol-based products, as consumers seek evidence-based solutions for skin, joint, and cognitive health.
Key macro drivers include the demographic shift: by 2030, 1 in 6 people globally will be aged 60 or over, according to the World Health Organization. This creates a massive addressable market for supplements targeting age-related decline. Additionally, the COVID-19 pandemic accelerated health consciousness, with 45% of consumers now prioritizing immune and longevity supplements. The Collagen Supplements Market alone accounts for over 40% of ingredient revenue, while the NMN Supplements Market is the fastest-growing at a CAGR of 12%.
Regionally, North America leads with a 35% share, followed by Europe and Asia-Pacific at 25% each. Asia-Pacific is expected to witness the highest growth rate at 10.2% CAGR, driven by expanding middle-class populations in China and India. The market faces challenges such as regulatory scrutiny and price sensitivity, but innovation in delivery formats and personalized nutrition offers significant opportunities.
| Segment | Growth Rate (CAGR %) | Market Share (%) | Key Demand Driver |
|---|---|---|---|
| Collagen | 9.5% | 42% | Skin health and joint support |
| Vitamins | 7.0% | 25% | General wellness and immunity |
| NMN | 12.0% | 10% | NAD+ enhancement and longevity |
| Resveratrol | 8.0% | 8% | Antioxidant and anti-inflammatory |
| Others | 6.5% | 15% | Niche applications |
The collagen segment dominates the anti-aging supplements market, generating over $2 billion in revenue in 2025. Its popularity stems from proven benefits for skin elasticity, joint health, and hair strength. The Collagen Supplements Market is expected to grow at a 9.5% CAGR through 2033, driven by innovations in hydrolyzed collagen and vegan alternatives. Within this segment, marine collagen is gaining traction, especially in Asia-Pacific, due to its high bioavailability and sustainable sourcing.
Margin pressures are evident as raw material costs for collagen fluctuate due to bovine and marine sourcing constraints. Companies are investing in vertical integration and alternative sources like fermentation-derived collagen to stabilize margins.
| Factor Type | Description | Impact Level | Timeline |
|---|---|---|---|
| Driver | Aging population: 1 in 6 people will be over 60 by 2030 | High | Long term |
| Driver | Rising health awareness post-COVID-19 | High | Short term |
| Driver | Technological advances in ingredient bioavailability | Medium | Long term |
| Restraint | Stringent regulations on health claims | High | Long term |
| Restraint | High cost of premium ingredients like NMN | Medium | Short term |
| Restraint | Supply chain disruptions for marine collagen | Medium | Short term |
Quantitative evaluation of catalysts shows that the aging population will add 1.4 billion people over 60 by 2030, directly expanding the consumer base. The pandemic-induced shift is quantified by a 20% increase in online supplement sales since 2019. On the restraint side, the FDA and EFSA have tightened rules on anti-aging claims, requiring clinical evidence. For instance, in 2024, EFSA rejected 15% of proposed health claims for collagen supplements. Additionally, NMN faces regulatory hurdles in some markets, with the FDA ruling it not a legal dietary supplement in the U.S., impacting the NMN Supplements Market. These bottlenecks necessitate strategic compliance and innovation.
| Company Name | Core Strength | Target Audience | Market Position |
|---|---|---|---|
| Shaklee Corporation | Science-backed formulations | Health-conscious adults | Leader |
| Thorne | Premium quality and testing | Affluent consumers | Leader |
| GNC Holdings | Retail network and brand recognition | Mass market | Challenger |
| Life Extension | Research-driven longevity products | Biohackers and seniors | Leader |
| ChromaDex | NMN and NR innovation | Longevity enthusiasts | Niche |
| Nu Skin Enterprises | Direct selling and anti-aging focus | Middle-aged women | Challenger |
| Oziva | Plant-based nutrition | Young Indian consumers | Niche |
| Date | Company | Event Type | Impact |
|---|---|---|---|
| Jan 2024 | ChromaDex | Launch | Introduced Niagen+ for NAD+ support |
| Mar 2024 | Nestlé Health Science | M&A | Acquired collagen brand Vital Proteins |
| Jun 2024 | Shaklee | Partnership | Collaborated with genomics firm for personalized supplements |
| Sep 2024 | Life Extension | Launch | Released resveratrol formulation with improved bioavailability |
| Nov 2024 | GNC | Partnership | Partnered with online platform to boost e-commerce |
| Region | Projected CAGR (%) | Base Year Valuation (2025) | Primary Catalyst | Regulatory Stringency |
|---|---|---|---|---|
| North America | 8.0% | $1.68B | Aging population, high awareness | High (FDA) |
| Europe | 7.5% | $1.20B | Preventive health trends | High (EFSA) |
| Asia-Pacific | 10.2% | $1.20B | Rising middle class, aging in Japan/China | Medium |
| South America | 6.5% | $0.38B | Increasing health expenditure | Low |
| Middle East & Africa | 7.0% | $0.34B | Urbanization and wellness trends | Low to Medium |
North America remains the most mature market, with a 35% share, but Asia-Pacific is the fastest-growing, driven by 10.2% CAGR. In Asia-Pacific, Japan and China are key markets due to their aging populations and traditional use of collagen. The Skin Health Supplements Market is particularly strong in this region, with Japan accounting for 25% of regional revenue. Europe follows with a focus on clean-label and sustainable products, though regulatory hurdles are high. South America and MEA offer untapped potential, with rising disposable incomes and awareness.
Major trade corridors for anti-aging supplements include North America to Asia-Pacific for premium ingredients like NMN, and Europe to North America for finished collagen products. Key net-exporting nations are the United States, Germany, and China, while net importers include Japan, South Korea, and the UAE. Tariff barriers are relatively low for nutraceuticals under WTO agreements, but non-tariff barriers such as labeling requirements and health claim approvals significantly impact trade. For instance, the EU's Novel Food Regulation adds 12–18 months to approval timelines, affecting shipments of NMN and resveratrol. In 2024, the U.S. imposed a 7.5% tariff on certain Chinese collagen imports, raising costs by $50 million annually. Conversely, India reduced import duties on raw materials to boost local manufacturing, benefiting the NMN Supplements Market. The Nutrigenomics Market, which focuses on gene-based nutrition, is expected to grow at 15% CAGR, influencing anti-aging supplement formulations.
Historical disruptions include the 2021 Texas freeze, which halted collagen production, and the 2022 Shanghai lockdown, impacting NMN exports. Current price trends show collagen prices rising 5% annually, while NMN prices have fallen 10% due to increased competition. Companies are mitigating risks through long-term contracts and alternative sourcing.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 8.5% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Nutraceutical Procurement Director | 30% |
| Anti-Aging Formulation R&D Manager | 30% |
| Dietary Supplement Regulatory Specialist | 20% |
| Global Supply Chain Manager | 20% |
| Company Type | Representation (%) |
|---|---|
| Collagen peptide manufacturers | 25% |
| NMN/NR ingredient suppliers | 20% |
| Contract supplement manufacturers | 25% |
| Retail pharmacy chains | 15% |
| Online supplement e-tailers | 15% |
The market declined by approximately 5% in 2020 due to supply chain disruptions, but rebounded with 9% growth in 2021. Permanent shifts include a 20% increase in online sales and a heightened focus on immune health, with 45% of consumers now prioritizing supplements that address both aging and immunity.
In 2024, ChromaDex launched a new NMN product targeting NAD+ decline, while Nestlé Health Science acquired a collagen supplement brand to expand its portfolio. Additionally, Shaklee Corporation partnered with a biotech firm to develop personalized anti-aging formulations, reflecting a trend toward strategic partnerships.
Key innovations include NAD+ precursors like NMN and NR, with ChromaDex's Niagen receiving FDA GRAS status. R&D is increasingly focused on bioavailability enhancement and personalized nutrition, leveraging nutrigenomics to tailor supplements based on genetic profiles.
The market was valued at $4.8 billion in 2025 and is projected to reach $9.2 billion by 2033, growing at a CAGR of 8.5%. This growth is driven by an aging global population and increasing consumer awareness of preventive health.
North America dominates with a 35% share, driven by high consumer awareness, an aging population, and strong retail presence of companies like GNC and Life Extension. The region also benefits from advanced regulatory frameworks and high disposable income.
Consumers are shifting toward online purchases, which accounted for 40% of sales in 2025, up from 25% in 2019. Demand for clean-label, vegan, and sustainably sourced ingredients is rising, with 60% of consumers willing to pay a premium for such products.
